Oberoi Realty Q1 Results: Profit falls 28% YoY to Rs 421.2 crore, revenue drop 30%
The company also witnessed a significant decline in revenue, which fell 29.7% YoY to ₹987.5 crore, down from ₹1,405 crore in the same period last year. The fall in revenue appears to have weighed heavily on operating performance as well.
On the operating front, EBITDA came in at ₹520.4 crore, a steep 36% decline from ₹815 crore a year ago. EBITDA margin also slipped to 52.7% from 58% YoY, reflecting the pressure on profitability despite a still-healthy margin profile by sector standards.
Oberoi Realty board has also declared an interim dividend of ₹2 per share for FY26. This amounts to 20% of the face value of each share (₹10). The decision was made during the board meeting held on July 21, 2025. Shareholders on record as of July 25, 2025, will be eligible for the dividend. The company has confirmed that the payout will be made on or before August 7, 2025.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
42 minutes ago
- Business Insider
Ocean Power signs reseller agreement in Mexico
Ocean Power (OPTT) announced the signing of a new reseller agreement with a Latin America-based partner focused on supporting the Mexican offshore and maritime markets. This partnership expands OPT's commercial footprint across Latin America. The agreement also includes a $3M purchase commitment for OPT's WAM-V Unmanned Surface Vehicles. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Yahoo
2 hours ago
- Yahoo
Straits Orthopaedics Expands Global Footprint with Acquisition of U.S.-Based Medin Technologies, Strengthening Orthopaedic Manufacturing Portfolio
PENANG, Malaysia, July 25, 2025--(BUSINESS WIRE)--Straits Orthopaedics (Mfg) Sdn Bhd ("Straits"), a leading Malaysia-based contract manufacturer specializing in the precision machining of orthopaedic implants and surgical instruments, today announced the successful acquisition of Medin Technologies, Inc. ("Medin"), a U.S.-based manufacturer of sterilization cases and trays for the orthopaedic sector operating two facilities in Totowa, New Jersey, and Manchester, New Hampshire. This strategic acquisition represents a pivotal step in Straits' growth trajectory, reinforcing its commitment to broadening both its product offerings and global manufacturing capabilities. With over 20 years of experience serving the global orthopaedic market, Straits is now uniquely positioned to deliver a more integrated and expansive suite of solutions to its global OEM partners. Hans de Waal, General Manager of Medin, said, "Medin Technologies is excited to become a part of the Straits Orthopaedics organization. Our company has been serving the orthopaedic market since 1979 and has become a major player in the case and tray market. Joining Straits enables the company to provide solutions across multiple segments as a global CMO capable of delivery fully kitted instrument sets ready for distribution." "We are excited to add Medin's case and tray product lines to our broad array of manufacturing capabilities," said Scott Gareiss, CEO of Straits. "Medin is recognized for their design expertise, vertical integration, and innovative quality controls for case and tray production used in systems for joint replacement, trauma, extremities, spine, power equipment, and more for medical device OEM's. The combination of Straits and Medin will enable us to serve our customers more broadly." Ewan Davis, Partner at Quadria Capital and Board Director of Straits Orthopaedics, added, "The addition of Medin demonstrates our continued focus on investing in and expanding the scope of services provided by Straits for our customers and ultimately increasing patient impact across the world. The combined businesses create a truly global footprint and is testament to the ambition and capabilities of this Malaysian orthopaedic contract manufacturing champion." Kirkland & Ellis and PwC served as advisors to Quadria and Straits. About Straits OrthopaedicsFounded in 2003 by TH Su in Penang, Straits Orthopaedics manufactures implants and instruments as a contract manufacturer serving orthopaedic OEM customers. Straits is a vertically integrated provider of precision machined products with in-house surface treatment, heat treatment, and sterile packaging. Please visit for more information. About Quadria CapitalFounded in 2012, Quadria Capital is Asia's premier healthcare investor managing over US$4 billion in assets across 27 investments in South and Southeast Asia including India, Vietnam, Indonesia, Malaysia and Singapore. Quadria Capital aims to create significant and sustainable shareholder value by partnering with exceptional healthcare businesses to enhance their impact and scale, while generating superior returns for investors. For more information, please visit View source version on Contacts Media Contact: Yvette Sign in to access your portfolio
Business Wire
2 hours ago
- Business Wire
Straits Orthopaedics Expands Global Footprint with Acquisition of U.S.-Based Medin Technologies, Strengthening Orthopaedic Manufacturing Portfolio
BUSINESS WIRE)--Straits Orthopaedics (Mfg) Sdn Bhd ('Straits'), a leading Malaysia-based contract manufacturer specializing in the precision machining of orthopaedic implants and surgical instruments, today announced the successful acquisition of Medin Technologies, Inc. ('Medin'), a U.S.-based manufacturer of sterilization cases and trays for the orthopaedic sector operating two facilities in Totowa, New Jersey, and Manchester, New Hampshire. This strategic acquisition represents a pivotal step in Straits' growth trajectory, reinforcing its commitment to broadening both its product offerings and global manufacturing capabilities. With over 20 years of experience serving the global orthopaedic market, Straits is now uniquely positioned to deliver a more integrated and expansive suite of solutions to its global OEM partners. Hans de Waal, General Manager of Medin, said, 'Medin Technologies is excited to become a part of the Straits Orthopaedics organization. Our company has been serving the orthopaedic market since 1979 and has become a major player in the case and tray market. Joining Straits enables the company to provide solutions across multiple segments as a global CMO capable of delivery fully kitted instrument sets ready for distribution.' 'We are excited to add Medin's case and tray product lines to our broad array of manufacturing capabilities,' said Scott Gareiss, CEO of Straits. 'Medin is recognized for their design expertise, vertical integration, and innovative quality controls for case and tray production used in systems for joint replacement, trauma, extremities, spine, power equipment, and more for medical device OEM's. The combination of Straits and Medin will enable us to serve our customers more broadly.' Ewan Davis, Partner at Quadria Capital and Board Director of Straits Orthopaedics, added, 'The addition of Medin demonstrates our continued focus on investing in and expanding the scope of services provided by Straits for our customers and ultimately increasing patient impact across the world. The combined businesses create a truly global footprint and is testament to the ambition and capabilities of this Malaysian orthopaedic contract manufacturing champion.' Kirkland & Ellis and PwC served as advisors to Quadria and Straits. About Straits Orthopaedics Founded in 2003 by TH Su in Penang, Straits Orthopaedics manufactures implants and instruments as a contract manufacturer serving orthopaedic OEM customers. Straits is a vertically integrated provider of precision machined products with in-house surface treatment, heat treatment, and sterile packaging. Please visit for more information. About Quadria Capital Founded in 2012, Quadria Capital is Asia's premier healthcare investor managing over US$4 billion in assets across 27 investments in South and Southeast Asia including India, Vietnam, Indonesia, Malaysia and Singapore. Quadria Capital aims to create significant and sustainable shareholder value by partnering with exceptional healthcare businesses to enhance their impact and scale, while generating superior returns for investors.
